Angiotensin II Upregulation of Cardiomyocyte Adiponectin Production Is Nitric Oxide/Cyclic GMP Dependent (Q44339880)

2 December 2017

title

Angiotensin II upregulation of cardiomyocyte adiponectin production is nitric oxide/cyclic GMP dependent (English)

1 reference

2 December 2017

Angiotensin II Upregulation of Cardiomyocyte Adiponectin Production Is Nitric Oxide/Cyclic GMP Dependent (English)

1 reference

Crossref

https://api.crossref.org/works/10.1097/MAJ.0B013E318203ABD5

25 November 2024

Bingyan Guo

1 reference

2 December 2017

Yongjun Li

1 reference

2 December 2017

Rui Han

1 reference

2 December 2017

Hong Zhou

1 reference

2 December 2017

Mei Wang

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 May 2011

1 reference

2 December 2017

May 2011

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21358315

full work available at URL

25 November 2024

https://api.elsevier.com/content/article/PII:S000296291531288X?httpAccept=text/xml

1 reference

Crossref

https://api.crossref.org/works/10.1097/MAJ.0B013E318203ABD5

https://api.elsevier.com/content/article/PII:S000296291531288X?httpAccept=text/plain

25 November 2024

1 reference

Crossref

https://api.crossref.org/works/10.1097/MAJ.0B013E318203ABD5

American Journal of the Medical Sciences

25 November 2024

published in

1 reference

2 December 2017

volume

341

1 reference

2 December 2017

1 reference

2 December 2017

page(s)

350-355

1 reference

Role of adiponectin receptors in endothelin-induced cellular hypertrophy in cultured cardiomyocytes and their expression in infarcted heart

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E318203ABD5

Circulating adiponectin concentrations in patients with congestive heart failure

25 November 2024

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E318203ABD5

Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure

25 November 2024

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E318203ABD5

Circulating Adiponectin Levels and Mortality in Elderly Men With and Without Cardiovascular Disease and Heart Failure

25 November 2024

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E318203ABD5

Adiponectin is released from the heart in patients with heart failure

25 November 2024

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E318203ABD5

The ventricular epicardial fat is related to the myocardial mass in normal, ischemic and hypertrophic hearts

25 November 2024

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E318203ABD5

Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart.

25 November 2024

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E318203ABD5

Pericardial fat accumulation in men as a risk factor for coronary artery disease

25 November 2024

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E318203ABD5

Cardiac angiotensin II formation in the clinical course of heart failure and its relationship with left ventricular function

25 November 2024

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E318203ABD5

Is angiotensin II a proliferative factor of cardiac fibroblasts?

25 November 2024

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E318203ABD5

Angiotensin AT1/AT2 receptors: regulation, signalling and function

25 November 2024

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E318203ABD5

PPARgamma-activating angiotensin type-1 receptor blockers induce adiponectin

25 November 2024

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E318203ABD5

Angiotensin II receptors subtypes mediate diverse gene expression profile in adult hypertrophic cardiomyocytes

25 November 2024

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E318203ABD5

Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT).

25 November 2024

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E318203ABD5

The comparative prognostic value of plasma neurohormones at baseline in patients with heart failure enrolled in Val-HeFT.

25 November 2024

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E318203ABD5

Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the Valsartan Heart Failure (Val-HeFT) data

25 November 2024

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E318203ABD5

Total and high molecular weight adiponectin, haemodynamics, and mortality in patients with chronic heart failure

25 November 2024

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E318203ABD5

Natriuretic peptides enhance the production of adiponectin in human adipocytes and in patients with chronic heart failure

25 November 2024

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E318203ABD5

Up-regulating the heme oxygenase system with hemin improves insulin sensitivity and glucose metabolism in adult spontaneously hypertensive rats

25 November 2024

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E318203ABD5

Adiponectin modulates carnitine palmitoyltransferase-1 through AMPK signaling cascade in rat cardiomyocytes

25 November 2024

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E318203ABD5

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

25 November 2024

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E318203ABD5

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

25 November 2024

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E318203ABD5

Angiotensin type-2 receptors and cardiovascular function: are angiotensin type-2 receptors protective?

25 November 2024

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E318203ABD5

Angiotensin II-induced vasodilation via type 2 receptor: role of bradykinin and nitric oxide

25 November 2024

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E318203ABD5

Adiponectin and adiponectin receptors

25 November 2024

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E318203ABD5

Relationship of adiponectin with markers of systemic inflammation, atherogenic dyslipidemia, and heart failure in patients with coronary heart disease

25 November 2024

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E318203ABD5

Adiponectin-mediated modulation of hypertrophic signals in the heart

25 November 2024

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E318203ABD5

Regulation of gene transcription of angiotensin II receptor subtypes in myocardial infarction

25 November 2024

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E318203ABD5

Differential distribution of angiotensin AT2 receptors in the normal and failing human heart

25 November 2024

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E318203ABD5

Adiponectin protects against angiotensin II-induced cardiac fibrosis through activation of PPAR-alpha

25 November 2024

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E318203ABD5

Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes

25 November 2024

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E318203ABD5

Endothelial AT 1 –Mediated Release of Nitric Oxide Decreases Angiotensin II Contractions in Rat Carotid Artery

25 November 2024

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E318203ABD5

Coronary Kinin Generation Mediates Nitric Oxide Release After Angiotensin Receptor Stimulation

25 November 2024

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E318203ABD5

AT 2 Receptor Stimulation Increases Aortic Cyclic GMP in SHRSP by a Kinin-Dependent Mechanism

25 November 2024

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E318203ABD5

The subtype-2 (AT2) angiotensin receptor regulates renal cyclic guanosine 3', 5'-monophosphate and AT1 receptor-mediated prostaglandin E2 production in conscious rats

25 November 2024

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E318203ABD5

Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors

25 November 2024

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E318203ABD5

Nitric oxide mediates the antiapoptotic effect of insulin in myocardial ischemia-reperfusion: the roles of PI3-kinase, Akt, and endothelial nitric oxide synthase phosphorylation

25 November 2024

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E318203ABD5

Adiponectin suppresses proliferation and superoxide generation and enhances eNOS activity in endothelial cells treated with oxidized LDL.

25 November 2024

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E318203ABD5

Adiponectin stimulates production of nitric oxide in vascular endothelial cells.

25 November 2024

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E318203ABD5

Stimulated HSP90 binding to eNOS and activation of the PI3-Akt pathway contribute to globular adiponectin-induced NO production: vasorelaxation in response to globular adiponectin

25 November 2024

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E318203ABD5

Cardiac Hypertrophy Is Associated With Decreased eNOS Expression in Angiotensin AT 2 Receptor–Deficient Mice

25 November 2024

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E318203ABD5

Spontaneous myocardial infarction in mice lacking all nitric oxide synthase isoforms

25 November 2024

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E318203ABD5

25 November 2024

Identifiers

1 reference

2 December 2017

1 reference